Omega‐3 vs placeboIADL · Apathy in people with mild‐to‐moderate Alzheimer's disease1 finding from 1 reviewOmega‐3 fatty acids for the treatment of dementia 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 22 participantsModerate